Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-463-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 30 November 2016 - 17 May 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP study conducted according to OECD test Guideline No. 492 without any deviation.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- Adopted 28 July 2015
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- French GLP Compliance Programme for chemical products (inspected on 23 - 24 April 2015 / signed on 23 October 2015)
Test material
- Reference substance name:
- alpha-pinene and beta-pinene dimers
- IUPAC Name:
- alpha-pinene and beta-pinene dimers
- Reference substance name:
- alpha-pinene and beta-pinene trimers
- IUPAC Name:
- alpha-pinene and beta-pinene trimers
- Reference substance name:
- alpha-pinene and beta-pinene tetramers
- IUPAC Name:
- alpha-pinene and beta-pinene tetramers
- Reference substance name:
- alpha-pinene and beta-pinene pentamers
- IUPAC Name:
- alpha-pinene and beta-pinene pentamers
- Test material form:
- liquid: viscous
- Details on test material:
- Batch No. 16-03 SI
Purity: 100% (UVCB substance)
Name of the test item (as cited in the study report): TERPENIC OLIGOMERS
Physical state: amber viscous liquid
Storage Conditions: +2°C to +8°C, under nitrogen and protected from light
Reassay date: 05 January 2017
Constituent 1
Constituent 2
Constituent 3
Constituent 4
Test animals / tissue source
- Species:
- other: Reconstructed human cornea-like epithelium tissues (EpiOcular™ tissue model)
- Strain:
- other: Not applicable
- Details on test animals or tissues and environmental conditions:
- - Justification of the test method and considerations regarding applicability: The EpiOcular™ Eye Irritation Test (EIT) was validated by the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) and Cosmetics Europe between 2008 and 2013. This test guideline is applicable to liquids and semi-solids, so is considered to be applicable to the test item.
CELL SYSTEM:
- EpiOcular™ OCL-212-ver2.0, supplied by MatTek Corporation (Bratislava, Slovakia).
- Lot No.: 23755
- Keratinocyte strain: 4F1188
- Analysis for potential biological contaminants: none detected (HIV-1, Hep. B and Hep. C virus; Bacteria, yeast and other fungi)
- Tissue viability: 1.355, within the acceptance criteria (1.1-3.0)
- Barrier function: 16.42 min, within the acceptance criteria (12.2-37.5)
- Sterility: Sterile
- Transport: Not specified
- Storage: On day of receipt of the EpiOcular™ tissues, the 12-tissues in their 24-well shipping container were equilibrated at room temperature for 15 minutes. Then the inserts (filter + epithelium) were gently removed from the agarose while avoiding leaving agarose on the polycarbonate filter. They were placed in 6 wells culture plate which had been previously filled with 1 mL of 37°C pre-warmed assay medium (MatTek Corporation, batch No. 120516MG) and incubated during 19 hours and 58 minutes at standard culture conditions.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- other: Killled control tissue
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 50 µL
- Concentration (if solution): not applicable
VEHICLE: Not applicable - Duration of treatment / exposure:
- 30 minutes
- Observation period (in vivo):
- Not applicable
- Duration of post- treatment incubation (in vitro):
- - 12-minute immersion period at room temperature
- 2-hour incubation at 37°C, 5% CO2 - Number of animals or in vitro replicates:
- 2 replicates
- Details on study design:
- - Details of the test procedure used
: procedure for liquids
* Pre-treatment: after an overnight incubation, tissues were pre-wetted with 20 µL of Ca2+Mg2+Free-DPBS. Then tissues were incubated for 30 minutes at standard culture conditions.
* Treatment: 50 µL of test item, positive or negative control was applied to the entire surface of 2 living RhCE tissue replicates and 2 killled DPBS pre-treated RhCE tissue replicates during 30 minutes at standard culture conditions.
* Post-exposure incubation period: after treatment, tissues were carefully washed by extensive rinsing with Ca2+Mg2+Free-DPBS. Rinsed tissues were checked for any coloration and for comparable colour with negative control treated tissues (whitish). The rinsing step was followed by a 12-minute immersion period at room temperature in 5 mL of fresh medium to remove any test item absorbed into the tissue. Then the RhCE constructs were incubated for 2 hours at standard culture conditions in 1 mL of fresh medium at 37°C, 5% CO2.
- Doses of test chemical and control substances used : 50 µL
- Duration and temperature of pre-treatment (30 minutes), exposure (30 minutes), post-exposure immersion (2 hours)
- Description of any modifications to the test procedure : None
- Indication of controls used for direct MTT-reducers and/or colouring test chemicals (if applicable) : Since the test item was identified as a direct MTT reducer, two killed control tissue models were added to the study which underwent the entire testing procedure to generate a nonspecific MTT reduction control. The test item did not interfere with the MTT assay, thus no non-specific coloration control was added to the study.
- Number of tissue replicates used per test chemical and controls (positive control, negative control, NSMTT, NSCliving): 2
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model :
If the test item-treated tissue viability is > 60% relative to the negative control treated tissue viability, the test item is labeled non-irritant.
If the test item-treated tissue viability is ≤ 60% relative to negative control treated tissue viability, the test item is identified potentially requiring classification and labelling according to UN GHS (Category 2 of Category 1.
According to OECD guideline 492 a single test composed of at least two tissue replicates should be sufficient for a test chemical, when the result is unequivocal. However, in cases of borderline results, such as non-concordant replicate measurements and/or mean percent tissue viability equal to 60±5%, a second test should be considered, as well as a third one in case of discordant results between the first two tests.
- Reference to historical positive and negative control results demonstrating suitable run acceptance criteria : Yes, attached to the study report.
* Historical negative control ranges 83.17 - 116.83%
* Historical positive control ranges 6.50 - 60.03%
- Complete supporting information for the specific RhCE tissue construct used : Yes, attached to the study report.
- Reference to historical data of the RhCE tissue construct : No
- Demonstration of proficiency in performing the test method before routine use by testing of the proficiency chemicals : Yes, attached to the study report.
- Positive and negative control means and acceptance ranges based on historical data : Yes
- Acceptable variability between tissue replicates for positive and negative controls: Yes
- Acceptable variability between tissue replicates for the test chemical: Yes
Results and discussion
In vitro
Results
- Irritation parameter:
- other: % Tissue viability
- Remarks:
- mean corrected percent viability
- Run / experiment:
- 1
- Value:
- 80.08
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100.00%
- Positive controls validity:
- valid
- Remarks:
- 37.65%
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: Not specified
DEMONSTRATION OF TECHNICAL PROFICIENCY: Yes
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Met, except for the difference of viability between the two tissues of the negative control group which was 33.66%, instead of =< 20% as initially scheduled. Considering the results obtained, this deviation has no impact on the conclusion of the study.
- Acceptance criteria met for positive control: met
Any other information on results incl. tables
Table 7.3.2/1: Mean OD570Values and Percentage Viabilities for the Negative Control Item, Positive Control Item, Test Item Killed Tissue and Test Item
Tissue | OD | Mean OD / disc (#) | Mean OD / product | Viability % | Mean viability % | Difference of viability % | Conclusion | ||
Negative control | 1 | 0.911 0.892 0.917 |
0.906 | 0.776 | 1116.83 | 100.00 | 33.66 | ||
2 | 0.617 0.659 0.660 |
0.645 | 83.17 | ||||||
Positive control | 3 | 0.308 0.313 0.319 |
0.313 | 0.292 | 40.36 | 37.65 | 5.42 | UN GHS Category 2 or 1 | |
4 | 0.269 0.273 0.271 |
0.271 | 34.95 | ||||||
Test item | 5 | 0.666 0.679 0.689 |
0.678 | 0.664 | 87.427 | 85.62 | 3.61 | ||
6 | 0.658 0.654 0.638 |
0.650 | 83.817 | ||||||
Test item killed control | 13 | 0.043 0.048 0.045 |
0.045 |
0.043 | 5.803 | 5.54 | 0.52 | ||
14 | 0.036 0.044 0.043 |
0.041 | 5.287 | ||||||
Test item corrected | 80.08 | No Category |
Note: the optical density was measured after a 1:2 dilution of the formazan extracts in isopropanol.
#: mean of 3 values (triplicate of the same extract)
OD: optical density
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Test item TERPENIC OLIGOMERS does not require classification for eye irritation or serious eye damage according to CLP Regulation EC No. 1272/2008 and GHS regulations.
- Executive summary:
A study was performed to assess the eye irritation potential of the test item by means of the Human Cornea Model Test. The study was conducted according to OECD Guideline No. 492 and in compliance with GLP.
Test item TERPENIC OLIGOMERS was applied, as supplied, at the dose of 50 µL, to 2 living and 2 killed PBS pre-treated RhCE (EpiOcularTMtissue model) during 30 minutes at 37°C, 5% CO2, 95% humidity (standard culture conditions). The exposure period was followed by extensive rinsing with PBS at room temperature, a 12-minute post-exposure immersion period at room temperature and a 2-hour post-exposure incubation at standard culture conditions. The tissue viability was measured by performing a MTT assay.
The mean corrected percent tissue viability of the RhCE replicates treated with test item TERPENIC OLIGOMERS was 80.08%, versus 37.65% in the positive control (Methyl acetate).
Therefore, test item TERPENIC OLIGOMERS does not require classification for eye irritation or serious eye damage according to CLP Regulation EC No. 1272/2008 and GHS Regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.